VitaSpring Biomedical Co. Ltd. reported earnings results for the second quarter and six months ended July 31, 2022. For the second quarter, the company reported net loss was USD 0.144137 million compared to net income of USD 0.250877 million a year ago.
For the six months, sales was USD 1.49 million compared to USD 1.92 million a year ago. Net income was USD 0.132521 million compared to USD 0.425839 million a year ago.